Pharmaceutical lactose industry trends point to $392.3 million by 2033: FMI

Based on the latest analysis by Future Market Insights, the global pharmaceutical lactose market is projected to reach USD 222.6 million in 2023, with an expected compound annual growth rate (CAGR) of 5.8% during the forecast period from 2023 to 2033. Total pharmaceutical lactose sales are projected to reach USD 392.3 million by 2033.

The growth of the pharmaceutical lactose market can be attributed to the rising demand for orally disintegrating tablets (ODTs) as lactose acts as an excellent carrier for such formulations. Moreover, the biocompatibility and biodegradability of lactose make it more attractive for various drug delivery systems. As the pharmaceutical industry focuses on patient-centric formulations, lactose helps in improving the taste, consistency, and stability of oral drugs, ultimately increasing patient compliance.

The increasing use of lactose as an ideal excipient in the emerging pharmaceutical sector is a significant factor driving the global market. Similarly, the increasing incidence of chronic diseases, development of new drugs, and increased investment in R&D are expected to facilitate the expansion of the global lactose pharmaceutical industry.

Over the years, lactose has become one of the most commonly used excipients in the pharmaceutical sector for the production of a wide range of solid dosage forms. It is used as a binder, carrier or diluent and helps pharmaceutical companies produce tablets with the appropriate hardness.

Rising production and consumption of solid dosage forms such as capsules and tablets is expected to boost demand for pharmaceutical lactose during the forecast period. Subsequently, rising demand for dry powder inhalation products will create growth opportunities for pharmaceutical lactose manufacturers.

Various forms of lactose are used in the production of drugs, i.e. α-lactose monohydrate, β-lactose, amorphous lactose and spray-dried lactose.

Growing health awareness, especially in developing regions, increasing popularity of preventive healthcare and rising healthcare expenditure are expected to contribute to further growth in the size of the pharmaceutical lactose industry over the next ten years.

Key findings from the pharmaceutical lactose market research:

The pharmaceutical lactose market in Mexico is forecasted to grow at a compound annual growth rate (CAGR) of approximately 8% over the next ten years.
In terms of product type, the α-lactose monohydrate segment will continue to lead the global pharmaceutical lactose industry during the forecast period.
The UK pharmaceutical lactose market is expected to be worth more than $184.8 million by 2033.
In 2023, the United States is expected to have approximately 78.3% market share of pharmaceutical lactose in North America.
By 2033, Mexico is expected to have about 5.3% share of the global pharmaceutical lactose market.

Who wins?

DFE Pharma, Ba’emek Advanced Technologies Ltd (Tnuva Group), Avantor, Inc., Alpavit Käserei Champignon Hofmeister GmbH & Co. KG, Lactose (India) Limited, Hoogwegt Groep BV, Hilmar Ingredients, Armor Pharma, Merck KgaA, Kerry plc, Milei GmbH, BASF SE, MEGGLE Excipients & Technology are some of the leading companies present in the global pharmaceutical lactose market.

Major pharmaceutical companies producing lactose are focusing on partnerships and joint ventures to expand their product offerings and strengthen their supply chain.

Get valuable information about Pharmaceutical Lactose Market

Future Market Insights, in its new offering, provides an unbiased analysis of the pharmaceutical lactose industry, presenting historical demand data (2018 to 2022) and forecast statistics for the period (2023 to 2033). The study reveals compelling insights on the demand based on product type (β-lactose, α-lactose monohydrate, amorphous lactose, spray-dried lactose) and region.

About the Food and Beverage section at Future Market Insights

Expert analysis, actionable insights and strategic recommendations – the Food & Beverage team at Future Market Insights helps clients around the world with their unique business intelligence needs. With a repertoire of over 1,000 reports and over 1 million data points, the team has been analyzing the food and beverage industry in 50+ countries for over a decade. The team provides comprehensive research and consulting services; contact us to learn how we can help.

Gain access to valuable information about each segment by purchasing now!

Pharmaceutical Lactose Market by Category

Product type:

β-lactose
α-lactose monohydrate
Amorphous lactose
Spray dried lactose

Region:

North America
Latin America
Europe
East Asia
South Asia
Middle East and Africa
Oceania

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award winner and member of the Greater New York Chamber of Commerce) offers in-depth insights into the factors driving market demand. FMI is a leading global provider of market intelligence, advisory services, consulting and events for the packaging, food and beverage, consumer technology, healthcare, industrial and chemical markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional and local expertise on various industry disciplines and trends in over 110 countries.

Contact FMI:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Apartment 401, Newark, Delaware – 19713, USA
Phone: +1-845-579-5705
For commercial inquiries: [email protected]
Website: https://www.futuremarketinsights.com
LinkedIn | Twitter| Blogs | YouTube